Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-25-021315
Filing Date
2025-05-01
Accepted
2025-05-01 07:04:06
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-05-01

Document Format Files

Seq Description Document Type Size
1 ARS avtx10-k2024printxready_ars.pdf ARS 16694546
  Complete submission text file 0001628280-25-021315.txt   22997021
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37590 | Film No.: 25899352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)